Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2006

01.01.2006 | Original Article

Serum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosis

verfasst von: Pedro Xavier, Luís Belo, Jorge Beires, Irene Rebelo, José Martinez-de-Oliveira, Nuno Lunet, Henrique Barros

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2006

Einloggen, um Zugang zu erhalten

Abstract

Objective: To compare serum levels of vascular endothelial growth factor (VEGF), tumor necrosis factor-alpha (TNF-α), and C-reactive protein (CRP) throughout the menstrual cycle in women with and without endometriosis and to quantify the association between these serum markers. Methods: Twenty five endometriosis patients (ASRM stage III–IV) and 13 controls were followed through one menstrual cycle. VEGF, TNF-α and CRP concentrations were measured with enzyme-linked immunosorbent assay in each of the four cycle phases (early and late proliferative and early and late secretory). Non-parametric methods and Pearson’s correlation coefficients were used for statistical analysis. Results: Increased serum levels of VEGF in secretory phases and of TNF-α in all cycle phases were observed. A positive correlation between CRP and VEGF was found in endometriosis patients but not in controls. Conclusions: Our results suggest that excessive systemic angiogenic activity is a feature of patients with endometriosis.
Literatur
1.
Zurück zum Zitat American Society for Reproductive Medicine (1997) Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67:817–821 American Society for Reproductive Medicine (1997) Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67:817–821
2.
Zurück zum Zitat Audebert A, Backstrom T, Barlow DH, Benagiano G, Brosens I, Buhler K, et’al (1992) Endometriosis 1991: a discussion document. Hum Reprod 7:432–435PubMed Audebert A, Backstrom T, Barlow DH, Benagiano G, Brosens I, Buhler K, et’al (1992) Endometriosis 1991: a discussion document. Hum Reprod 7:432–435PubMed
3.
Zurück zum Zitat Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR, et’al (2002) Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 17:426–431CrossRefPubMed Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR, et’al (2002) Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 17:426–431CrossRefPubMed
4.
Zurück zum Zitat Braun DP, Dmowski WP (1998) Endometriosis: abnormal endometrium and dysfunctional immune response. Curr Opin Obstet Gynecol 10:365–369CrossRefPubMed Braun DP, Dmowski WP (1998) Endometriosis: abnormal endometrium and dysfunctional immune response. Curr Opin Obstet Gynecol 10:365–369CrossRefPubMed
5.
Zurück zum Zitat Darai E, Detchev R, Hugol D, Quang NT (2003) Serum and cyst fluid levels of interleukin (IL)-6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours. Hum Reprod 18:1681–1685CrossRefPubMed Darai E, Detchev R, Hugol D, Quang NT (2003) Serum and cyst fluid levels of interleukin (IL)-6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours. Hum Reprod 18:1681–1685CrossRefPubMed
6.
Zurück zum Zitat Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M (1998) Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 13:1686–1690CrossRefPubMed Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M (1998) Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 13:1686–1690CrossRefPubMed
7.
8.
Zurück zum Zitat Fasciani A, D’Ambrogio G, Bocci G, Luisi S, Artini PG, Genazzani AR (2001) Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathology. Fertil Steril 75:1218–1221CrossRefPubMed Fasciani A, D’Ambrogio G, Bocci G, Luisi S, Artini PG, Genazzani AR (2001) Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathology. Fertil Steril 75:1218–1221CrossRefPubMed
9.
Zurück zum Zitat Gagné D, Pagé M, Robitaille G, Hugo P, Gosselin D (2003) Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum Reprod 18:1674–1680CrossRefPubMed Gagné D, Pagé M, Robitaille G, Hugo P, Gosselin D (2003) Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum Reprod 18:1674–1680CrossRefPubMed
10.
Zurück zum Zitat Harada T, Iwabe T, Terakawa N (2001) Role of cytokines in endometriosis. Fertil Steril 76:1–10CrossRefPubMed Harada T, Iwabe T, Terakawa N (2001) Role of cytokines in endometriosis. Fertil Steril 76:1–10CrossRefPubMed
11.
Zurück zum Zitat Healy DL, Rogers PA, Hii L, Wingfield M (1998) Angiogenesis: a new theory for endometriosis. Hum Reprod Update 4:736–740CrossRefPubMed Healy DL, Rogers PA, Hii L, Wingfield M (1998) Angiogenesis: a new theory for endometriosis. Hum Reprod Update 4:736–740CrossRefPubMed
12.
Zurück zum Zitat Iwabe T, Harada T, Tsudo T, Nagano Y, Tanikawa M, Terakawa N (2000) Tumor necrosis factor-α promotes proliferation of the endometriotic stromal cells by inducing interleukin-8 gene and protein expression. J Clin Endocrinol Metab 85:824–829CrossRefPubMed Iwabe T, Harada T, Tsudo T, Nagano Y, Tanikawa M, Terakawa N (2000) Tumor necrosis factor-α promotes proliferation of the endometriotic stromal cells by inducing interleukin-8 gene and protein expression. J Clin Endocrinol Metab 85:824–829CrossRefPubMed
13.
Zurück zum Zitat Ladoux A, Frelin C (1993) Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun 195:1005–1010CrossRefPubMed Ladoux A, Frelin C (1993) Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun 195:1005–1010CrossRefPubMed
14.
Zurück zum Zitat Matalliotakis I, Neonaki M, Zolindaki A, Hassan E, Georgoulias V, Koumantakis E (1997) Changes in immunologic variables (TNF-α, sCD8 and sCD4) during danazol treatment in patients with endometriosis. Int J Fertil Womens Med 42:211–214PubMed Matalliotakis I, Neonaki M, Zolindaki A, Hassan E, Georgoulias V, Koumantakis E (1997) Changes in immunologic variables (TNF-α, sCD8 and sCD4) during danazol treatment in patients with endometriosis. Int J Fertil Womens Med 42:211–214PubMed
15.
Zurück zum Zitat Matalliotakis IM, Goumenou AG, Koumantakis GE, Neonaki MA, Koumantakis EE,Dionyssopoulou E (2003) Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines. Int Immunopharmacol 3:81–89CrossRefPubMed Matalliotakis IM, Goumenou AG, Koumantakis GE, Neonaki MA, Koumantakis EE,Dionyssopoulou E (2003) Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines. Int Immunopharmacol 3:81–89CrossRefPubMed
16.
Zurück zum Zitat Matarese G, Alviggi C, Sanna V, Howard JK, Lord GM, Carravetta C, et’al (2000) Increased leptin levels in serum and peritoneal fluid of patients with pelvic endoemtriosis. J Clin Endocrinol Metab 85:2483–2487CrossRefPubMed Matarese G, Alviggi C, Sanna V, Howard JK, Lord GM, Carravetta C, et’al (2000) Increased leptin levels in serum and peritoneal fluid of patients with pelvic endoemtriosis. J Clin Endocrinol Metab 85:2483–2487CrossRefPubMed
17.
Zurück zum Zitat Missmer SA, Cramer DW (2003) The epidemiology of endometriosis. Obstet Gynecol Clin N Am 30:1–19CrossRef Missmer SA, Cramer DW (2003) The epidemiology of endometriosis. Obstet Gynecol Clin N Am 30:1–19CrossRef
18.
Zurück zum Zitat Packard CJ, O’Reilly DSJ, Caslake MJ, McMahon AD, Ford I, Cooney J, et’al (2000) Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med 343:1148–1155CrossRefPubMed Packard CJ, O’Reilly DSJ, Caslake MJ, McMahon AD, Ford I, Cooney J, et’al (2000) Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med 343:1148–1155CrossRefPubMed
19.
Zurück zum Zitat Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohi J, Simón C (1998) The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production. Fertil Steril 70:425–431CrossRefPubMed Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohi J, Simón C (1998) The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production. Fertil Steril 70:425–431CrossRefPubMed
20.
Zurück zum Zitat Seli E, Berkkanoglu M, Arici A (2003) Pathogenesis of endometriosis. Obstet Gynecol Clin N Am 30:41–61CrossRef Seli E, Berkkanoglu M, Arici A (2003) Pathogenesis of endometriosis. Obstet Gynecol Clin N Am 30:41–61CrossRef
21.
Zurück zum Zitat Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, et’al (1996) Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 81:3112–3118CrossRefPubMed Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, et’al (1996) Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 81:3112–3118CrossRefPubMed
22.
Zurück zum Zitat Steff AM, Gagne D, Page M, Rioux A, Hugo P, Gosselin D (2004) Serum concentrations of insulin-like growth factor-1, soluble tumor necrosis factor receptor-1 and angiogenin in endometriosis patients. Am J Reprod Immunol 51:166–173CrossRefPubMed Steff AM, Gagne D, Page M, Rioux A, Hugo P, Gosselin D (2004) Serum concentrations of insulin-like growth factor-1, soluble tumor necrosis factor receptor-1 and angiogenin in endometriosis patients. Am J Reprod Immunol 51:166–173CrossRefPubMed
23.
Zurück zum Zitat Vinatier D, Dufour P, Oosterlynck D (1996) Immunological aspects of endometriosis. Hum Reprod Update 2:371–384CrossRefPubMed Vinatier D, Dufour P, Oosterlynck D (1996) Immunological aspects of endometriosis. Hum Reprod Update 2:371–384CrossRefPubMed
24.
Zurück zum Zitat Vercellini P, Trespidi L, De Giorgi O, Cortesi I, Parazzini F, Crosignani PG (1996) Endometriosis and pelvic pain: relation to disease stage and localization. Fertil Steril 65:299–304PubMed Vercellini P, Trespidi L, De Giorgi O, Cortesi I, Parazzini F, Crosignani PG (1996) Endometriosis and pelvic pain: relation to disease stage and localization. Fertil Steril 65:299–304PubMed
Metadaten
Titel
Serum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosis
verfasst von
Pedro Xavier
Luís Belo
Jorge Beires
Irene Rebelo
José Martinez-de-Oliveira
Nuno Lunet
Henrique Barros
Publikationsdatum
01.01.2006
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2006
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-005-0080-4

Weitere Artikel der Ausgabe 4/2006

Archives of Gynecology and Obstetrics 4/2006 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.